The FDA has approved Lipfendra, a new cholesterol-lowering medication that offers another treatment option for adults with high LDL ("bad") cholesterol. The approval marks a significant advance in heart health care, providing physicians with an additional therapy to help reduce cardiovascular risk alongside healthy lifestyle changes. https://2daybulletins.com/